GlassScriptPhysician profile
Joel Cohn
NPI 1922006873
$6,989.55
in general payments reported to CMS, 2019-2025
36 companies · $714 in 2025
The $714 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,505 · 2020: $491 · 2021: $247 · 2022: $1,027 · 2023: $1,558 · 2024: $1,447 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,719.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,352.14 | 2019-2025 | Eluvia, Watchman Access System, Avvigo Guidance System |
| Abbott Laboratories | $722.36 | 2019-2024 | Cardiomems, Esprit |
| Shockwave Medical, INC | $625.75 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $318.83 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.22 | 2019-2025 | Jardiance |
| Amgen INC. | $284.60 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $242.93 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $232.18 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $231.97 | 2019-2025 | |
| Penumbra, INC. | $199.44 | 2019-2024 | Indigo System |
| Pfizer INC. | $132.36 | 2019-2025 | |
| Cardiovascular Systems INC. | $120.33 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $109.81 | 2023-2025 | Opsumit, Uptravi |
| Philips North America LLC | $106.58 | 2025 | Coronary Other |
| Medtronic, INC. | $92.92 | 2021-2025 | Linq II, Micra |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $92.76 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm |
| Biotronik INC. | $83.07 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.44 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.25 | 2022-2025 | Lifevest |
| Inspire Medical Systems, INC. | $68.74 | 2023 | Inspire |
| Medtronic Vascular, INC. | $63.38 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $61.61 | 2023-2025 | Brilinta, Wainua |
| Inari Medical, INC. | $54.15 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bridgebio Pharma, INC. | $46.81 | 2025 | Attruby |
| Atricure, INC. | $43.57 | 2023 | |
| Sanofi-Aventis U.S. LLC | $33.71 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $27.77 | 2022 | |
| Alnylam Pharmaceuticals INC. | $24.26 | 2025 | Onpattro |
| Edwards Lifesciences Corporation | $23.57 | 2023 | Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals International, Plc | $23.54 | 2024 | Arcalyst |
| Heartflow, INC. | $23.13 | 2023 | Ffrct |
| Teleflex LLC | $22.48 | 2019 | |
| Siemens Medical Solutions USA, INC. | $19.06 | 2023 | Corpath Imaging System |
| Amarin Pharma, INC. | $16.82 | 2020 | |
| Livanova USA, INC. | $14.89 | 2022 | |
| Alexion Pharmaceuticals, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.